Timeliness of DTaP-IPV-Hib vaccination and development of atopic dermatitis between 4 months and 1 year of age—Register-based cohort study
The Journal of Allergy and Clinical Immunology: In Practice | Oct 29, 2020
Secukinumab demonstrates high efficacy and a favourable safety profile in paediatric patients with severe chronic plaque psoriasis: 52‐week results from a Phase 3 double‐blind randomised, controlled trial
Journal of the European Academy of Dermatology and Venereology | Oct 21, 2020